Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2Gastrointestinal 2

Conditions

Peritoneal Neoplasms 9Colorectal Neoplasms 8Appendiceal Neoplasms 7Stomach Neoplasms 5Ovarian Neoplasms 3Uterine Neoplasms 2Uterine Cervical Neoplasms 2Pseudomyxoma Peritonei 2Neoplasm Metastasis 2Peritoneal Diseases 1Necrosis 1Mesothelioma 1Gastrointestinal Neoplasms 1Fallopian Tube Neoplasms 1

Interventions

Oxaliplatin 2Mitomycin 2Leucovorin 2Hyperthermic Intraperitoneal Chemotherapy 2Surveys and Questionnaires 1Standard of Care 1Specimen Handling 1Referral and Consultation 1Radiosurgery 1Psychiatric Rehabilitation 1Pharmacogenomic Testing 1Observation 1Nivolumab 1Methods 1Magnetic Resonance Spectroscopy 1Ipilimumab 1Ifosfamide 1Gemcitabine 1Fluorouracil 1Floxuridine 1Early Intervention, Educational 1Doxorubicin 1Cisplatin 1Carboplatin 1CTLA-4 Antigen 1Behavior Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Pseudomyxoma Peritonei × Mitomycin × Gynecologic × Clear all
NCT04779554 2026-04-01

Flat Dose vs. Weight-based IP Chemotherapy for CRS/HIPEC

University of Kentucky

Phase 2 Recruiting
100 enrolled
GastrointestinalGynecologic

Appendiceal Neoplasms, Peritoneal Neoplasms, Pseudomyxoma Peritonei, Colorectal Neoplasms

NCT02040142 2024-10-24

HIPEC for Peritoneal Carcinomatosis

Albert Einstein College of Medicine

Phase 2 Completed
51 enrolled 12 charts
GastrointestinalGynecologic

Appendiceal Neoplasms, Peritoneal Neoplasms, Pseudomyxoma Peritonei, Stomach Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡